How Zenosense, Inc. (ZENO) Aims to Revolutionize Lung Cancer Detection
More Americans die from lung cancer than any other type of cancer. The CDC reports that in 2011, out of the 207,339 Americans diagnosed with lung cancer, 156,953 people died from the disease. Science is advancing screen cancer screening technology, though current methods unarguably have room for improvement. Mortality rates were reduced by 20% in patients that underwent screening with low-dose computed tomography (CT) compared to radiographic screening, according to the National Institutes of Health. Despite the effectiveness and benefits of CT screening, this method carries a higher risk of false-positive results and unnecessary invasive procedures compared to X-ray screening,…